(FDA) has approved its use only for the symptomatic relief of patients with interstitial cystitis. A 1978 study concluded that DMSO brought significant relief to the majority of the 213 patients with inflammatory genitourinary disorders that were studied.

In 2009, the first to obtain FDA approval for topical DMSO usage was PENNSAID, which contains diclofenac in